BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 10320637)

  • 41. The Qa-1b molecule binds to a large subpopulation of murine NK cells.
    Salcedo M; Bousso P; Ljunggren HG; Kourilsky P; Abastado JP
    Eur J Immunol; 1998 Dec; 28(12):4356-61. PubMed ID: 9862372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells.
    Lohwasser S; Hande P; Mager DL; Takei F
    Eur J Immunol; 1999 Mar; 29(3):755-61. PubMed ID: 10092077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.
    Borrego F; Kabat J; Kim DK; Lieto L; Maasho K; Peña J; Solana R; Coligan JE
    Mol Immunol; 2002 Feb; 38(9):637-60. PubMed ID: 11858820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.
    Vance RE; Jamieson AM; Cado D; Raulet DH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):868-73. PubMed ID: 11782535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
    Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
    Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of DAP12 with activating CD94/NKG2C NK cell receptors.
    Lanier LL; Corliss B; Wu J; Phillips JH
    Immunity; 1998 Jun; 8(6):693-701. PubMed ID: 9655483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
    Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
    Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.
    Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD
    Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.
    López-Botet M; Carretero M; Pérez-Villar J; Bellón T; Llano M; Navarro F
    Immunol Res; 1997; 16(2):175-85. PubMed ID: 9212363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CD94/NKG2C-type lectin receptor complex in recognition of HLA class I molecules.
    López-Botet M; Carretero M; Bellón T; Pérez-Villar JJ; Llano M; Navarro F
    Res Immunol; 1997; 148(3):155-9. PubMed ID: 9255866
    [No Abstract]   [Full Text] [Related]  

  • 55. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.
    Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A
    Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    Vance RE; Kraft JR; Altman JD; Jensen PE; Raulet DH
    J Exp Med; 1998 Nov; 188(10):1841-8. PubMed ID: 9815261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
    Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells.
    Ho EL; Heusel JW; Brown MG; Matsumoto K; Scalzo AA; Yokoyama WM
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6320-5. PubMed ID: 9600963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.
    Shum BP; Flodin LR; Muir DG; Rajalingam R; Khakoo SI; Cleland S; Guethlein LA; Uhrberg M; Parham P
    J Immunol; 2002 Jan; 168(1):240-52. PubMed ID: 11751968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
    Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
    Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.